Marken at a Glance
Marken’s superior global team and network of facilities bridge the distance between patients and the precious resources of life science companies.
In existence since 1980, Marken prides itself on discerning and satisfying the premium logistical needs of the pharmaceutical, biotechnology and clinical research industries. Our global reach and expertise guarantees sophisticated handling of biological specimens and temperature-sensitive clinical trial supplies, all coordinated and managed locally through strategically-placed offices in 24 countries worldwide. Our extensive depot network supports cold storage and distribution of life science assets such as critical medications and diagnostic equipment.
• Our volumes: 65% samples, 25% drug/kits, and 10% other
• We serve over 49,000 clinical sites in more than 150 countries
• We operate from 29 offices and 5 Marken owned depot locations
Board of Directors
The Marken Board of Directors convenes ten times per year and provides expert guidance on strategy, finance, business development, sales and marketing and corporate governance. The board is comprised of:
- Wes Wheeler
- Chris O’Connell
- Doaa Fathallah
- Bob Ellis
- Tim Tyson
- Michael O’Donnell
- Graham Villiers – Observer
- Natalia Tsitoura – Observer